Berikutnya

Putar otomatis

CAR T-Cell Therapy for Relapsed/Refractory CLL

2 Tampilan • 07/14/23
Membagikan
Menanamkan
administrator
administrator
Pelanggan
0

The panelists provide insight on the use of chimeric antigen receptor T-cell therapy for chronic lymphocytic leukemia and the TRANSCEND CLL-004 trial of liso-cel (JCAR017) in relapsed/refractory disease.

Menampilkan lebih banyak
0 Komentar sort Sortir dengan
Komentar Facebook

Berikutnya

Putar otomatis